ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | – | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 48 | +71.4% | 0.00% | – |
| Q3 2020 | $0 | – | 28 | -9.7% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | -53.7% | 0.00% | – |
| Q3 2019 | $0 | – | 67 | -18.3% | 0.00% | – |
| Q2 2019 | $0 | – | 82 | +115.8% | 0.00% | – |
| Q1 2019 | $0 | – | 38 | -56.8% | 0.00% | – |
| Q4 2018 | $0 | – | 88 | +6.0% | 0.00% | – |
| Q3 2018 | $0 | – | 83 | +112.8% | 0.00% | – |
| Q2 2018 | $0 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,826,980 | $12,606,000 | 6.68% |
| Omega Fund Management, LLC | 912,693 | $6,096,000 | 1.65% |
| BVF INC/IL | 3,005,589 | $20,739,000 | 1.13% |
| Sio Capital Management, LLC | 656,043 | $4,527,000 | 0.90% |
| Avidity Partners Management LP | 2,087,800 | $14,406,000 | 0.67% |
| Vivo Capital, LLC | 1,516,865 | $10,466,000 | 0.60% |
| Opaleye Management Inc. | 271,350 | $1,872,000 | 0.37% |
| Eventide Asset Management | 2,335,169 | $15,307,000 | 0.30% |
| CAXTON CORP | 26,590 | $183,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $1,725,000 | 0.17% |